CTIS.eu › Cities › Norway › Stavanger
Stavanger
Norway
125 total trials
65 recruiting
2024-511492-15-00
5
2021-12-09
Duchenne Muscular Dystrophy
2023-509864-96-00
4
2021-12-07
Mantle Cell Lymphoma (MCL)
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
2023-509208-14-00
5
2021-09-28
MULTIPLE MYELOMA
2023-510194-34-00
4
2021-06-18
Multiple myeloma
2024-510716-71-00
5
2020-10-21
Multiple Sclerosis
2022-502887-19-00
5
2020-08-18
Diffuse Large B-Cell Lymphoma
2023-503591-25-00
5
2020-06-09
Non-small cell lung cancer
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia
2022-501817-29-00
5
2018-11-27
High Risk Non-muscle invasive bladder cancer
2024-517417-32-00
4
2018-11-22
CHRONIC MYELOID LEUKEMIA
2023-510298-33-00
4
2016-11-29
Prostate Cancer
2024-517321-99-00
4
2016-08-01
Myeloma multiplex
2022-501253-37-00
4
2016-02-02
(A) Anal Squamous Cell Carcinoma,
(B) Biliary Adenocarcinoma (gallblad
2025-521107-42-00
4
2025-11-25
Alzheimer's Disease
2023-510282-10-00
3
2025-02-11
Mild Cognitive Impairment
2023-505083-11-01
4
2024-05-07
Alzheimer's Disease
2023-503814-62-00
4
2024-02-06
Multiple sclerosis
2022-501074-19-00
10
2023-10-13
Hidradenitis suppurativa
2022-501850-12-00
4
2023-03-15
Psoriasis
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
2022-502437-25-00
4
2022-08-15
advanced or metastatic non-small cell lung cancer
2022-501132-42-00
6
2022-08-02
Monkeypox virus disease
Showing 97–120 of 125 trials